rs1131692304
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001368894.2(PAX6):c.445C>T(p.Gln149*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001368894.2 stop_gained
Scores
Clinical Significance
Conservation
Publications
- aniridia 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
- PAX6-related ocular dysgenesisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Peters anomalyInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- coloboma, ocular, autosomal dominantInheritance: AD Classification: STRONG Submitted by: PanelApp Australia
- diabetes mellitusInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- aniridia-cerebellar ataxia-intellectual disability syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- foveal hypoplasia-presenile cataract syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- isolated aniridiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- isolated optic nerve hypoplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal dominant keratitisInheritance: Unknown, AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAX6 | NM_001368894.2 | c.445C>T | p.Gln149* | stop_gained | Exon 8 of 14 | ENST00000640368.2 | NP_001355823.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Aniridia 1 Pathogenic:2
_x000D_ Criteria applied: PVS1, PS4_MOD, PM2_SUP -
- -
Aniridia 1;C0344559:Irido-corneo-trabecular dysgenesis Pathogenic:1
Loss-of-function variants in PAX6 are known to be pathogenic (PMID: 12634864). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This sequence change creates a premature translational stop signal (p.Gln135*) in the PAX6 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been reported in individuals affected with aniridia (PMID: 28321846, 9482572). This variant is also known as c.765C>T in the literature. ClinVar contains an entry for this variant (Variation ID: 430994). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at